These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 21632017)
1. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Limia A; Pachón I Euro Surveill; 2011 May; 16(21):. PubMed ID: 21632017 [TBL] [Abstract][Full Text] [Related]
2. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Watson M; Shaw D; Molchanoff L; McInnes C Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598 [TBL] [Abstract][Full Text] [Related]
3. Introduction of human papillomavirus (HPV) vaccination in Sweden. Tegnell A; Dillner J; Andrae B Euro Surveill; 2009 Feb; 14(6):. PubMed ID: 19215721 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide. Owsianka B; Gańczak M Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448 [TBL] [Abstract][Full Text] [Related]
5. Coverage from Ontario, Canada's school-based HPV vaccine program: the first three years. Wilson SE; Harris T; Sethi P; Fediurek J; Macdonald L; Deeks SL Vaccine; 2013 Jan; 31(5):757-62. PubMed ID: 23246265 [TBL] [Abstract][Full Text] [Related]
6. Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008. Simoens C; Sabbe M; Van Damme P; Beutels P; Arbyn M Euro Surveill; 2009 Nov; 14(46):. PubMed ID: 19941796 [TBL] [Abstract][Full Text] [Related]
7. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Smith MA; Lew JB; Walker RJ; Brotherton JM; Nickson C; Canfell K Vaccine; 2011 Nov; 29(48):9112-22. PubMed ID: 21419773 [TBL] [Abstract][Full Text] [Related]
8. [HPV vaccination coverage in German girls: results of the KiGGS study: first follow-up (KiGGS Wave 1)]. Poethko-Müller C; Buttmann-Schweiger N; Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jul; 57(7):869-77. PubMed ID: 24950836 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Guerry SL; De Rosa CJ; Markowitz LE; Walker S; Liddon N; Kerndt PR; Gottlieb SL Vaccine; 2011 Mar; 29(12):2235-41. PubMed ID: 21288799 [TBL] [Abstract][Full Text] [Related]
10. Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain. Gauthier A; Martín-Escudero V; Moore L; Ferko N; de Sanjosé S; Pérez-Escolano I; Catalá-López F; Ferrer E; Bosch FX Eur J Public Health; 2008 Dec; 18(6):674-80. PubMed ID: 18641420 [TBL] [Abstract][Full Text] [Related]
11. Uptake of the HPV vaccination programme in England: a cross-sectional survey of young women attending sexual health services. Sacks RJ; Copas AJ; Wilkinson DM; Robinson AJ Sex Transm Infect; 2014 Jun; 90(4):315-21. PubMed ID: 24636998 [TBL] [Abstract][Full Text] [Related]
12. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey. Arrossi S; Maceira V; Paolino M; Sankaranarayanan R Vaccine; 2012 Mar; 30(14):2467-74. PubMed ID: 22266289 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention. Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417 [TBL] [Abstract][Full Text] [Related]
14. Factors influencing uptake of HPV vaccination among girls in Germany. Schülein S; Taylor KJ; König J; Claus M; Blettner M; Klug SJ BMC Public Health; 2016 Sep; 16():995. PubMed ID: 27645711 [TBL] [Abstract][Full Text] [Related]
15. "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination. Cooper Robbins SC; Bernard D; McCaffery K; Brotherton J; Garland S; Skinner SR Vaccine; 2010 Apr; 28(19):3398-408. PubMed ID: 20199758 [TBL] [Abstract][Full Text] [Related]
16. [Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses]. Westra TA; Daemen T; Postma MJ; Wilschut JC Ned Tijdschr Geneeskd; 2009; 153():A356. PubMed ID: 19930733 [TBL] [Abstract][Full Text] [Related]
17. School-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program. Reeve C; De La Rue S; Pashen D; Culpan M; Cheffins T Commun Dis Intell Q Rep; 2008 Mar; 32(1):94-8. PubMed ID: 18522312 [TBL] [Abstract][Full Text] [Related]
18. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands. van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785 [TBL] [Abstract][Full Text] [Related]
19. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Gertig DM; Brotherton JM; Saville M Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430 [TBL] [Abstract][Full Text] [Related]
20. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark. Widgren K; Simonsen J; Valentiner-Branth P; Mølbak K Vaccine; 2011 Dec; 29(52):9663-7. PubMed ID: 22015392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]